Category - Pharmaceuticals Market Research Report

Next-Generation Contraceptives Market Size, Share & Trends Analysis Distribution by Gender (Male, Female), End User (Hospital Pharmacies, Retail Pharmacies, Online Channels), Offering (Drugs, Devices), and Segment Forecasts, 2024-2031

Next-Generation Contraceptives Market Size is predicted to exhibit an 8.2% CAGR during the forecast period for 2024-2031. Next-generation contraceptives represent a promising frontier in reproductive health, containing a diverse array of innovative methods designed to prevent pregnancy effectively. For men, ongoing research includes the development of hormonal and non-hormonal options such as a pill that inhibits fertility by blocking vitamin ...

Report ID: 2534 |

Delivery: Immediate |

Published: February 2025 |

No. of Pages: 180

Liposomal Vitamins and Minerals Market Size, Share & Trends Analysis Report By Product Type (Vitamins (Vitamin C, Vitamin A, Vitamin B12, Vitamin E, Vitamin K, Combinations (Vitamin B Complex, Vitamin D3 & K2, Others), Minerals (Iron (Fe), Magnesium (Mg), Zinc (Zn), Others), Collagen, Glutathione, Curcumin, Melatonin, Others), By Formulation, By End-user, By Region, And By Segment Forecasts, 2024-2031

The Liposomal Vitamins and Minerals Market Size is predicted to raise at a 6.4% CAGR during the forecast period for 2024-2031. Liposomal vitamins and minerals are dietary additives that use the liposome delivery mechanism to supply nutrients. It is well recognized that this way of safeguarding vital nutrients increases the likelihood that the tiny intestines will absorb them, enabling the dietary additive to produce the desired effects. Liposo...

Report ID: 2914 |

Delivery: Immediate |

Published: December 2024 |

No. of Pages: 172

Peptide Therapeutics Contract API Manufacturing Market Size, Share & Trends Analysis Report By Scale Of Operation (Preclinical/Clinical And Commercial), Type Of Synthesis Method Used (Non-Chemical Synthesis Method And Chemical Synthesis Method), And Enterprise Type (Large Enterprises And Small And Medium Enterprises), Region And Segment Forecasts, 2024-2031

The Peptide Therapeutics Contract API Manufacturing Market Size is valued at USD 2.36 billion in 2023 and is predicted to reach USD 3.77 billion by the year 2031 at a 6.3% CAGR during the forecast period for 2024-2031. Peptide therapeutics contract API manufacturing is a technique of extending the production of drugs with active pharmaceutical components (APIs) or the parts that provide an external entity with the desired results. The increasi...

Report ID: 2915 |

Delivery: Immediate |

Published: December 2024 |

No. of Pages: 165

Gene-to-Patient Market Size, Share & Trends Analysis Report By Type (Gene Therapy, Gene Editing, Gene Silencing), By Application (Cancer Treatment, Genetic Disorders, Cardiovascular Diseases, Rare Diseases, Infectious Diseases), By End-user (Hospitals, Research Institutes, Biopharmaceutical Companies, Diagnostic Laboratories), By Technology, By Distribution Channel, By Region, And By Segment Forecasts, 2024-2031

The Gene-to-Patient Market Size is valued at USD 134.6 billion in 2023 and is predicted to reach USD 341.4 billion by the year 2031 at a 12.5% CAGR during the forecast period for 2024-2031. The gene-to-patient method intends to diagnose, treat, or prevent genetic diseases by creating and administering gene therapies that correct genetic information within a patient's cells. Beginning with the creation of gene therapy and continuing through its...

Report ID: 2905 |

Delivery: Immediate |